Ketamine enhances structural plasticity in human dopaminergic neurons:possible relevance for treatment-resistant depression

被引：3
|
作者：
Ginetta Collo [1 ,2 ]
Emilio Merlo Pich [3 ,4 ]
机构：
[1] Department of Molecular and Translational Medicine,Section of Pharmacology,University of Brescia
[2] Department of Biomedicine,University of Basel
[3] Neuroscience Therapeutic Area Unit,Takeda Pharmaceuticals International
来源：
Neural Regeneration Research | 2018年 / 13卷 / 04期
关键词：
MEK; ERK; Ketamine enhances structural plasticity in human dopaminergic neurons:possible relevance for treatment-resistant depression; TRD; MDD;
D O I：
暂无
中图分类号：
R749.4 [情感性精神病];
学科分类号：
100205 ;
摘要：
Depression refers to a series of mental health issues characterized by loss of interest and enjoyment in everyday life,low mood and selected emotional,cognitive,physical and behavioral symptoms.Depression is a common disorder,affecting 5–15%of the general population.When diagnosed as major depressive disorder(MDD),patients are currently
引用
收藏
页码：645 / 646
页数：2
相关论文
共 50 条
  • [41] Ketamine for Treatment-Resistant Depression A Gateway to Novel Treatment Approaches
    Limandri, Barbara J.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (10) : 11 - 14
  • [42] mTOR controls structural plasticity of dopaminergic neurons: implication in the actions of ketamine
    Collo, G.
    Cavalleri, L.
    Mora, C.
    Chiamulera, C.
    Millan, M. J.
    Pich, E. Merlo
    Spano, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S145 - S146
  • [43] Low-dose ketamine infusion in treatment-resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment-resistant depression
    Chen, Mu-Hong
    Wu, Hui-Ju
    Li, Cheng-Ta
    Lin, Wei-Chen
    Tsai, Shih-Jen
    Hong, Chen-Jee
    Tu, Pei-Chi
    Bai, Ya-Mei
    Mao, Wei-Chung
    Su, Tung-Ping
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (02)
  • [44] Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depression
    Cook, John
    Halaris, Angelos
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2022, 119
  • [45] Possible usefulness of tianeptine in treatment-resistant depression
    Tobe, Edward H.
    Rybakowski, Janusz K.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2013, 17 (04) : 313 - 316
  • [46] Ketamine cystitis following ketamine therapy for treatment-resistant depression - case report
    Chang, Minna
    Juruena, Mario F.
    Young, Allan H.
    BMC PSYCHIATRY, 2024, 24 (01)
  • [47] The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
    Hashimoto, Kenji
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2014, 12 (01) : 72 - 73
  • [48] Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
    Minna Chang
    Mario F Juruena
    Allan H Young
    BMC Psychiatry, 24
  • [49] In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response
    Holsinger, Tracey
    Riordan, Paul
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (09) : JC105 - JC105
  • [50] Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
    Kwasny, Aleksander
    Cubala, Wieslaw Jerzy
    Wlodarczyk, Adam
    Pastuszak, Krzysztof
    PHARMACOLOGICAL REPORTS, 2024, 76 (06) : 1325 - 1332
12345